Mutual of America Capital Management LLC Raises Stake in Clorox Co. (CLX)
Mutual of America Capital Management LLC boosted its position in Clorox Co. (NYSE:CLX) by 5.6% during the third quarter, Holdings Channel reports. The fund owned 15,958 shares of the company’s stock after buying an additional 852 shares during the period. Mutual of America Capital Management LLC’s holdings in Clorox were worth $1,998,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of CLX. Physicians Financial Services Inc. boosted its stake in shares of Clorox by 3.6% in the third quarter. Physicians Financial Services Inc. now owns 9,564 shares of the company’s stock worth $1,197,000 after buying an additional 330 shares during the last quarter. Northeast Investment Management boosted its stake in shares of Clorox by 0.9% in the third quarter. Northeast Investment Management now owns 105,348 shares of the company’s stock worth $13,187,000 after buying an additional 975 shares during the last quarter. Valley National Advisers Inc. boosted its stake in shares of Clorox by 0.5% in the third quarter. Valley National Advisers Inc. now owns 849 shares of the company’s stock worth $106,000 after buying an additional 4 shares during the last quarter. Argentus Capital Management LLC boosted its stake in shares of Clorox by 0.9% in the third quarter. Argentus Capital Management LLC now owns 2,446 shares of the company’s stock worth $306,000 after buying an additional 21 shares during the last quarter. Finally, Mizuho Trust & Banking Co. Ltd. boosted its stake in shares of Clorox by 6.6% in the third quarter. Mizuho Trust & Banking Co. Ltd. now owns 231,172 shares of the company’s stock worth $28,938,000 after buying an additional 14,385 shares during the last quarter. 69.32% of the stock is currently owned by institutional investors and hedge funds.
Clorox Co. (NYSE:CLX) traded down 1.81% on Wednesday, hitting $115.56. The stock had a trading volume of 1,833,760 shares. The stock’s 50 day moving average is $117.36 and its 200 day moving average is $127.31. The stock has a market cap of $14.88 billion, a price-to-earnings ratio of 23.26 and a beta of 0.36. Clorox Co. has a one year low of $111.24 and a one year high of $140.47.
Clorox (NYSE:CLX) last released its earnings results on Wednesday, November 2nd. The company reported $1.36 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.42 by $0.06. Clorox had a return on equity of 250.82% and a net margin of 11.27%. The firm earned $1.44 billion during the quarter, compared to analyst estimates of $1.24 billion. During the same quarter last year, the business posted $1.32 EPS. The firm’s revenue was up 3.8% on a year-over-year basis. Analysts anticipate that Clorox Co. will post $5.32 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Stockholders of record on Wednesday, January 25th will be paid a $0.80 dividend. This represents a $3.20 annualized dividend and a dividend yield of 2.77%. The ex-dividend date of this dividend is Monday, January 23rd. Clorox’s dividend payout ratio (DPR) is presently 64.26%.
A number of research analysts have recently issued reports on the company. B. Riley reiterated a “neutral” rating and set a $123.00 target price on shares of Clorox in a research report on Wednesday. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Friday, November 18th. Wells Fargo & Co. reiterated a “market perform” rating on shares of Clorox in a research report on Tuesday, November 15th. RBC Capital Markets reiterated a “sector perform” rating and set a $115.00 target price (down previously from $121.00) on shares of Clorox in a research report on Thursday, November 3rd. Finally, Royal Bank Of Canada decreased their target price on Clorox from $121.00 to $115.00 and set a “sector perform” rating on the stock in a research report on Thursday, November 3rd. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. Clorox presently has a consensus rating of “Hold” and a consensus price target of $128.50.
In other news, EVP Laura Stein sold 38,882 shares of the firm’s stock in a transaction on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the sale, the executive vice president now owns 48,501 shares in the company, valued at approximately $6,387,096.69. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.74% of the stock is currently owned by insiders.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.